This study is looking at how inhaled vaporized cannabis affects people with opioid use disorder (OUD). Researchers want to see if cannabis can help with opioid withdrawal symptoms. You might be able to join if you are between 18 and 55 years old and have opioid use disorder, but are not currently seeking treatment for it. You cannot join if you have other medical conditions that need ongoing medical care. The study will compare cannabis to a placebo (an inactive substance) and also look at the effects of an intranasal opioid. The main goal is to measure changes in opioid withdrawal severity using a Visual Analog Scale (VAS), which is a way to rate your symptoms. There are plans to include 15 participants, but the current status of the study is unclear.

Study design

This is an interventional study that plans to enroll 15 participants. It uses a double-blind approach, meaning neither you nor the study staff will know if you are receiving cannabis, a placebo, or an intranasal opioid.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint, opioid withdrawal severity, is measured as a change from baseline, but the duration of follow-up is not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.